The workshop has proven to be a fast and efficient way to vet projects and business ideas and launch pre-seed stage companies. Out of the teams that came to the past workshops held in Switzerland, several for-profit ventures were created or empowered following participation. We are very proud to mention that since their participation to the workshop, many of them have won prizes in Switzerland and the US or have received other international distinctions.
A new approach to make current insulin therapy safer and more effective for more than 30 million T1D patients.
Procavea Biotech develops innovative molecular delivery solutions to enable both RNA and small molecule medicines and addresses unmet clinical needs.
Arcoscreen’s mission is to help pharmaceutical compagnies identify promising G protein Coupled Receptor (GPCR) drugs in primary cells to get faster from research to clinical trials.
ExoSort has a unique technology which can efficiently sort cellular components from bodily fluids which carry important information for the detection of illnesses such as cancer.
FluoSphera’s technology better predicts the effects of molecules to help biotech and pharmaceutical companies to discover more efficient drugs with less adverse side effects, and to reduce animal experimentation.
CELLEC BIOTEK AG was founded as a spin-off of a lab of University Hospital Basel, Switzerland, active in the world of Tissue Engineering and Regenerative Medicine.
The ETH spinoff Hades.ai (now Pallon) is devoted to fast and objective sewer inspections. It uses machine learning to detect defects in sewer inspection videos. The method is faster, more objective and less error-prone.
It brings a time-of-flight mass spectrometer with high sensitivity into industrial process monitoring and surveillance applications.
Velox Therapeutics developed an anticoagulant that does not increase the bleeding risk, thus lowering some safety issues related to current drugs.
Adiposs is a Swiss biotech start-up company developing medical imaging products and technologies for early detection of cachexia
Nanolive SA developed a revolutionary microscope based on an exclusive technology which allows the exploration of a living cell in 3D without labeling and damaging it.
Morphotonix developed a technological platform which integrates complex custom-holographic-like diffractive elements on 3D metallic master moulds as a solution for brand-owners.
Cellestia Biotech is a biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.
TwentyGreen produces a triple active probiotic that addresses the major problems of intensive animal farming.
SwissDeCode develops a technology that allows anyone to check the DNA of their food while on the go.